2023/12/04

年末年始の休業日につきまして

2023/11/01

年度末 NGS受託解析ディスカウントキャンペーンのお知らせ

2023/10/11

第46回日本分子生物学会年会2023に企業出展致します。

2023/10/06

NGS EXPO 2023に企業展示致します。

2023/10/06

BioJapan / 再生医療JAPAN / healthTECH JAPAN 2023に株式会社 新興精機と共同で企業展示致しました。

2023/10/06

第82回日本癌学会学術総会に企業展示致しました。

2023/04/27

新年度 NGS受託解析ディスカウントキャンペーンのお知らせ

2023/04/27

GW休業につきまして

June 27, 2022

Press Release "Success in Development of New Technology for Highly Sensitive and Accurate Detection and Analysis of Trace Amounts of RNA at the Single Cell Level" (Paper published in Communications Biology, a sister journal of Nature.)

August 06, 2021

Our paper on highly sensitive cDNA amplification method (TAS-Seq method) was published in preprint server

May 14, 2021

Outsourcing agreement with Cancer Precision Medicine

June 22, 2022

Certified by Becton Dickinson Japan K.K. as a service provider using the BD Rhapsody™ Single Cell Analysis System

June 03, 2020

Lectured at LINK-J online symposium "Application of T cell receptor repertoire analysis and single cell gene expression analysis technology to cancer immunotherapy

February 12, 2020

The project has been selected for the research and development grant project in 2019 by Mitsubishi UFJ Technology Development Foundation

February 05, 2020

IGT introduced our company at the Meditational Nanotechnology Research Meeting

October 16, 2019

Exhibited at the Showcase conference of university-launched startups and ecosystem development

October 16, 2019

Certified by the Tokyo University of Science as a venture company originating from the Tokyo University of Science

December 16, 2019

Became a member of the Japan BioVenture Promotion Association

October 09, 2019

We will be exhibiting at the Tokyo University of Science booth at BioJapan 2019

August 29, 2019

Flash talk at the Single Cell Genomics Research Conference 2019 poster session

Aug 26, 2019

Introduction of IGT's business at the 35th TLSK pitch meeting